Pharma Foods International Co., Ltd. (TYO:2929)
Japan · Delayed Price · Currency is JPY 556.00
+2.00 (0.36%)
Aug 4, 2026, 11:12 AM JST
TYO:2929 Financials Overview
Financials in millions JPY. Fiscal year is August - July.
Millions JPY. Fiscal year is Aug - Jul.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Apr '26 Apr 30, 2026 | Jul '25 Jul 31, 2025 | Jul '24 Jul 31, 2024 | Jul '23 Jul 31, 2023 | Jul '22 Jul 31, 2022 | Jul '21 Jul 31, 2021 |
Revenue Revenue Growth | 66,998 | 65,260 | 62,147 | 68,572 | 60,185 | 46,752 |
Revenue Growth | 8.42% | 5.01% | -9.37% | 13.94% | 28.73% | 204.51% |
Gross Profit Gross Profit Growth | 54,054 | 52,584 | 48,752 | 55,279 | 48,108 | 39,725 |
Operating Income Operating Income Growth | 1,155 | 2,369 | 5,114 | 3,610 | 1,080 | 5,674 |
Net Income Net Income Growth | 430 | 368 | 3,205 | 3,081 | -374 | 3,841 |
Earnings Per Share EPS Growth | 14.86 | 12.80 | 112.69 | 106.70 | -12.89 | 132.14 |
EPS Growth | 87.59% | -88.64% | 5.62% | - | - | 456.13% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Apr '26 Apr 30, 2026 | Jul '25 Jul 31, 2025 | Jul '24 Jul 31, 2024 | Jul '23 Jul 31, 2023 | Jul '22 Jul 31, 2022 | Jul '21 Jul 31, 2021 |
B to C Business B to C Business Growth | 58,736 | 56,730 | 52,543 | 59,788 | 51,886 | 43,524 |
Other Other Growth | 31 | 15 | 16 | 21 | - | - |
Bio Medical Business Bio Medical Business Growth | 322 | 331 | 478 | 343 | 220 | 375 |
B to B Business B to B Business Growth | 7,908 | 8,182 | 9,108 | 8,418 | 8,079 | 2,852 |
Total Total Growth | 66,997 | 65,258 | 62,145 | 68,570 | 60,185 | 46,751 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Apr '26 Apr 30, 2026 | Jul '25 Jul 31, 2025 | Jul '24 Jul 31, 2024 | Jul '23 Jul 31, 2023 | Jul '22 Jul 31, 2022 | Jul '21 Jul 31, 2021 |
Cash & Investments Cash & Investments Growth | 8,765 | 9,157 | 15,666 | 16,306 | 8,845 | 9,794 |
Total Debt Total Debt Growth | 17,211 | 12,631 | 16,891 | 20,096 | 16,857 | 4,897 |
Net Cash (Debt) Net Cash Growth | -8,446 | -3,474 | -1,225 | -3,790 | -8,012 | 4,897 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -290.81 | -120.87 | -43.07 | -131.25 | -276.14 | 168.47 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Apr '26 Apr 30, 2026 | Jul '25 Jul 31, 2025 | Jul '24 Jul 31, 2024 | Jul '23 Jul 31, 2023 | Jul '22 Jul 31, 2022 | Jul '21 Jul 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -3,667 | -1,092 | 5,486 | 6,125 | -6,065 | 5,938 |
Capital Expenditures CapEx Growth | -871 | -891 | -841 | -386 | -467 | -154 |
Free Cash Flow Free Cash Flow Growth | -4,538 | -1,983 | 4,645 | 5,739 | -6,532 | 5,784 |
Free Cash Flow Growth | - | - | -19.06% | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Apr '26 Apr 30, 2026 | Jul '25 Jul 31, 2025 | Jul '24 Jul 31, 2024 | Jul '23 Jul 31, 2023 | Jul '22 Jul 31, 2022 | Jul '21 Jul 31, 2021 |
Gross Margin | - | 80.58% | 78.45% | 80.62% | 79.93% | 84.97% |
Operating Margin | 1.72% | 3.63% | 8.23% | 5.27% | 1.79% | 12.14% |
Pretax Margin | 1.50% | 3.73% | 8.10% | 5.17% | 2.36% | 12.33% |
Profit Margin | 0.64% | 0.56% | 5.16% | 4.49% | -0.62% | 8.22% |
FCF Margin | -6.77% | -3.04% | 7.47% | 8.37% | -10.85% | 12.37% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 4, 2026 | Jul '25 Jul 31, 2025 | Jul '24 Jul 31, 2024 | Jul '23 Jul 31, 2023 | Jul '22 Jul 31, 2022 | Jul '21 Jul 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 25.000 | 25.000 | 25.000 | 22.000 | 20.000 | 20.000 |
Dividend Per Share Growth | 0% | 0% | 13.64% | 10.00% | 0% | 135.29% |
Dividend Yield | 4.48% | 2.93% | 2.43% | 1.44% | 1.52% | 0.78% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 4, 2026 | Jul '25 Jul 31, 2025 | Jul '24 Jul 31, 2024 | Jul '23 Jul 31, 2023 | Jul '22 Jul 31, 2022 | Jul '21 Jul 31, 2021 |
PE Ratio | 37.29 | 69.60 | 9.64 | 15.69 | - | 21.92 |
P/FCF Ratio | - | - | 6.65 | 8.42 | - | 14.55 |
PS Ratio | 0.24 | 0.39 | 0.50 | 0.71 | 0.71 | 1.80 |